logo

Oramed Pharmaceuticals Inc. (ORMP)



Trade ORMP now with
  Date
  Headline
5/3/2022 8:13:29 AM Oramed Completes Patient Enrollment In Phase 3 Oral Insulin Study ORA-D-013-1
4/5/2022 8:27:04 AM Oramed Granted NASH Patent In Europe
4/5/2022 8:25:00 AM Oramed Granted NASH Patent in Europe (Press Release)
4/4/2022 8:30:38 AM Oramed Appoints Yadin Rozov To Board
1/12/2022 8:50:00 AM Oramed : Oral Insulin Program Continues To Advance With Topline Efficacy Data Expected In H2 2022
12/29/2021 6:03:48 AM Oravax Medical Signs Deal For Initial Pre-Purchase Of 10 Mln Doses Of Oral COVID-19 Vaccines With Tan Thanh
12/14/2021 8:14:32 AM Oramed Subsidiary Oravax Announces First Participant Enrolled In Phase 1 Oral COVID-19 Vaccine Trial In South Africa
12/8/2021 7:31:58 AM Oramed Pharma Appoints Netanel Derovan As Chief Legal Officer And Company Secretary, Effective Jan 9, 2022
12/8/2021 7:30:00 AM Oramed Pharmaceuticals Appoints Chief Legal Officer (Press Release)
11/23/2021 8:27:39 AM Oramed Reaches 75% Enrollment In Phase 3 Oral Insulin Study On Type 2 Diabetes
11/18/2021 7:45:37 AM Oramed Subsidiary Oravax Medical And Genomma Form JV To Develop And Commercialize Oral COVID-19 Vaccine In Mexico
10/29/2021 7:29:01 AM Oramed Says Oravax's Oral COVID-19 Vaccine Gets South African Approval To Begin Phase 1 Trial
9/15/2021 8:12:41 AM Oramed Says Phase 2 Oral Insulin Non-alcoholic Steatohepatitis Trial Reaches Over 50% Enrollment
8/24/2021 8:30:49 AM Oramed Enrolls Over 25% In Its Second Of Two Concurrent Phase 3 Oral Insulin Trials